Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer

被引：0
|
作者：
Ma, G. [1 ]
Xia, T. [1 ]
Liu, X. [1 ]
Wang, S. [1 ]
机构：
[1] Nanjing Med Univ, Dept Breast Surg, Affiliated Hosp 1, Nanjing, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
227
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 8 条
  • [1] Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer
    Ma, Ge
    Jiang, Yi
    Liang, Mengdi
    Li, JiaYing
    Wang, Jingyi
    Mao, Xinrui
    Veeramootoo, Jordee Selvamanee
    Xia, Tiansong
    Liu, Xiaoan
    Wang, Shui
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [2] Aneuploid Circulating Endothelial Cells with Prognostic Value in Locally Advanced Breast Cancer Patients After Neoadjuvant Chemotherapy
    Li, Minghui
    Liu, Yuelin
    Han, Xu
    Li, Tao
    Zhang, Zhizheng
    Xue, Ningyi
    Liang, Mengdi
    Ma, Ge
    Xia, Tiansong
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 761 - 768
  • [3] Role of aneuploid circulating tumor cells and CD31+ circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC
    Zhang, Tongmei
    Zhang, Lina
    Gao, Yuan
    Wang, Ying
    Liu, Yanxia
    Zhang, Hongmei
    Wang, Qunhui
    Hu, Fanbin
    Li, Jie
    Tan, Jinjing
    Wang, Daisy Dandan
    Gires, Olivier
    Lin, Peter Ping
    Li, Baolan
    MOLECULAR ONCOLOGY, 2021, 15 (11) : 2891 - 2909
  • [4] CD8+ Serum as a predictor of Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer
    Qodir, Nur
    Umar, Mulawan
    Darwin, Nopriansyah
    Theodorus
    Journal of Physics: Conference Series, 2019, 1246 (01):
  • [5] Monitoring circulating tumor cells (CTCs) during neoadjuvant chemotherapy for large operable and locally advanced breast cancer in a randomized phase II trial.
    Pierga, J-Y
    Mathiot, C.
    Asselah, J.
    Brain, E.
    Tresca, P.
    Espie, M.
    Sigal-Zafrani, B.
    Dieras, V
    Delaloge, S.
    Salmon, R.
    Mignot, L.
    Marty, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S153 - S153
  • [6] Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy
    Akkiprik, Mustafa
    Koca, Sinan
    Ugurlu, M. Umit
    Ekren, Ruchan
    Eyuboglu, Irem Peker
    Alan, Ozkan
    Erzik, Can
    Amuran, Gokce Gullu
    Telli, Tugba Akin
    Gulluoglu, M. Bahadir
    Sezerman, Ugur
    Yumuk, Perran Fulden
    CLINICAL BREAST CANCER, 2020, 20 (04) : 332 - +
  • [7] Dynamic Contrast-Enhanced MRI in Monitoring Changes in Tumor-Associated Stroma During Treatment With Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
    Singer, L.
    Jones, E.
    Newitt, D.
    Kornak, J.
    Hylton, N.
    Park, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S194 - S194
  • [8] Monitoring Circulating Tumor Cells (CTC) and Circulating Endothelial Cells (CEC) during Neoadjuvant Combination of Trastuzumab and Bevacizumab with Chemotherapy in HER2 Overexpressing Inflammatory Breast Cancer (IBC): An Ancillary Study of BEVERLY 2 Multicenter Phase II Trial
    Pierga, J-Y
    Bidard, F-C
    Petit, T.
    Delozier, T.
    Ferrero, J-M
    Campone, M.
    Gligorov, J.
    Lerebours, F.
    Roche, H.
    Kraemer, S.
    Mathiot, C.
    Viens, P.
    CANCER RESEARCH, 2010, 70
1